Health Condition 1: null- Symptomatic patients with benign prostatic enlargement
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Recurrent urinary retention(drug-refractory). 2.Patients with symptoms who had failed standard medical therapy (alpha-blockers, 5-alpha reductase inhibitors). 3.Patients with an active sexual life, the ability to ejaculate and a desire to preserve ejaculation.
Exclusion criteria
Exclusion criteria: 1.ASA grade III or more. 2.Documented or suspected prostate cancer. 3.Neurological diseases, neurogenic bladder and voiding dysfunction. 4.Urethral strictures, malignancies of the upper or lower urinary tract. 5.Sexual disturbances, preoperative ejaculation dysfunction. 6.Bilateral upper tracts dilatation with or without elevation of creatinine, or 7.Pelvic pain syndrome.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ejaculation after operationTimepoint: At minimum 2 months outcome will be assessed. Questionnaires of International index of erectile function -5 along with question 9 of questionnaires International index of erectile function-15 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Ejaculatory projection score â?? pre and post operative period 2. Maximum urinary flow/post void residue/The International Prostate Symptom Score/Ouality of life â?? pre and post op Timepoint: At minimum 2 months outcome will be assessed. 1.Ejaculatory projection score 2. Maximum urinary flow/post void residue/The International Prostate Symptom Score/Ouality of life | — |
Countries
Bangladesh, India
Contacts
Christian Medical College